- Home
- MTEK vs BFRI Comparison
MTEK vs BFRI Comparison
Compare MTEK & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MTEK | BFRI |
|---|---|---|
| Founded | 2008 | 1997 |
| Country | Israel | United States |
| Employees | N/A | 94 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 12.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MTEK | BFRI |
|---|---|---|
| Price | $1.40 | $1.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | ★ 156.3K | 117.9K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $0.54 |
| 52 Week High | $4.27 | $1.18 |
Technical Indicators
Market Signals| Indicator | MTEK | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 61.86 |
| Support Level | $1.08 | $0.79 |
| Resistance Level | $1.50 | $1.08 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 25.00 | 57.45 |
Price Performance
Historical ComparisonAbout MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.